Alpine Immune Sciences Analysis

Alpine Stock Analysis Notes

About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.64. Alpine Immune Sciences last dividend was issued on the 25th of July 2017. The entity had 1:4 split on the 25th of July 2017. Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmuneinflammatory disorders, and other diseases. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington. Alpine Immune operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 85 people. For more info on Alpine Immune Sciences please contact Mitchell MD at 206 788 4545 or go to https://www.alpineimmunesciences.com.

Alpine Immune Sciences Investment Alerts

Alpine Immune Sciences Upcoming and Recent Events

Alpine Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.46 B.

Alpine Profitablity

The company has Profit Margin (PM) of (0.65) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (3.23) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $3.23.

Alpine Immune Sciences Insider Trading Activities

Alpine Immune Outstanding Bonds

Alpine Immune Predictive Daily Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how Alpine Immune prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Alpine shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Alpine Immune. By using and applying Alpine Stock analysis, traders can create a robust methodology for identifying Alpine entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.